155 related articles for article (PubMed ID: 25689690)
1. Serum Adenosine Deaminase (ADA) Activity: A Novel Screening Test to Differentiate HIV Monoinfection From HIV-HBV and HIV-HCV Coinfections.
Abdi M; Rahbari R; Khatooni Z; Naseri N; Najafi A; Khodadadi I
J Clin Lab Anal; 2016 May; 30(3):200-3. PubMed ID: 25689690
[TBL] [Abstract][Full Text] [Related]
2. Analysis of serum adenosine deaminase (ADA) and ADA1 and ADA2 isoenzyme activities in HIV positive and HIV-HBV co-infected patients.
Khodadadi I; Abdi M; Ahmadi A; Wahedi MS; Menbari S; Lahoorpour F; Rahbari R
Clin Biochem; 2011 Aug; 44(12):980-3. PubMed ID: 21640091
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of serum adenosine deaminase activity in HIV infected patients of Kurdish population.
Abdi M; Ahmadi A; Roshany D; Khodadadi I; Javid S; Shahmohammad-Nezhad S; Sharifipour M; Hoseini J
Clin Lab; 2013; 59(7-8):757-62. PubMed ID: 24133903
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
[TBL] [Abstract][Full Text] [Related]
5. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study.
Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA
J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase isoenzymes in liver disease.
Kobayashi F; Ikeda T; Marumo F; Sato C
Am J Gastroenterol; 1993 Feb; 88(2):266-71. PubMed ID: 8424431
[TBL] [Abstract][Full Text] [Related]
7. Characterization of total adenosine deaminase activity (ADA) and its isoenzymes in saliva and serum in health and inflammatory conditions in four different species: an analytical and clinical validation pilot study.
Contreras-Aguilar MD; Tvarijonaviciute A; Monkeviciene I; Martín-Cuervo M; González-Arostegui LG; Franco-Martínez L; Cerón JJ; Tecles F; Escribano D
BMC Vet Res; 2020 Oct; 16(1):384. PubMed ID: 33046093
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
[TBL] [Abstract][Full Text] [Related]
9. Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy.
Chittiprol S; Satishchandra P; Bhimasenarao RS; Rangaswamy GR; Sureshbabu SV; Subbakrishna DK; Satish KS; Desai A; Ravi V; Shetty KT
Clin Chim Acta; 2007 Feb; 377(1-2):133-7. PubMed ID: 17049340
[TBL] [Abstract][Full Text] [Related]
10. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
[TBL] [Abstract][Full Text] [Related]
11. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal.
Bhattarai M; Baniya JB; Aryal N; Shrestha B; Rauniyar R; Adhikari A; Koirala P; Oli PK; Pandit RD; Stein DA; Gupta BP
Biomed Res Int; 2018; 2018():9241679. PubMed ID: 29487874
[TBL] [Abstract][Full Text] [Related]
13. Prognostic markers in HIV mono-and co-infected individuals: A study from Karachi-Pakistan.
Shaukat SN; Khan S; Raza A; Khanani R; Ghayaz A; Kazmi SU
J Infect Public Health; 2018; 11(2):250-254. PubMed ID: 28844443
[TBL] [Abstract][Full Text] [Related]
14. A dual role for Mannan-binding lectin-associated serine protease 2 (MASP-2) in HIV infection.
Boldt AB; Beltrame MH; Catarino SJ; Meissner CG; Tizzot R; Messias-Reason IJ
Mol Immunol; 2016 Oct; 78():48-56. PubMed ID: 27588826
[TBL] [Abstract][Full Text] [Related]
15. Systemic Elevation of Proinflammatory Interleukin 18 in HIV/HCV Coinfection versus HIV or HCV Monoinfection.
Veenhuis RT; Astemborski J; Chattergoon MA; Greenwood P; Jarosinski M; Moore RD; Mehta SH; Cox AL
Clin Infect Dis; 2017 Mar; 64(5):589-596. PubMed ID: 27927859
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study.
Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T
J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535
[TBL] [Abstract][Full Text] [Related]
18. Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies.
Jou E; Gligich O; Chan AC; Mohan D; Felsen UR; Ayyappan S; Billett HH; Hui EP; Chan AT; Raghupathy R
Ann Hematol; 2016 Mar; 95(4):575-80. PubMed ID: 26747296
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infections.
Tsuboi I; Sagawa K; Shichijo S; Yokoyama MM; Ou DW; Wiederhold MD
Clin Diagn Lab Immunol; 1995 Sep; 2(5):626-30. PubMed ID: 8548545
[TBL] [Abstract][Full Text] [Related]
20. Plasma adenosine deaminase2: a marker for human immunodeficiency virus infection.
Niedzwicki JG; Kouttab NM; Mayer KH; Carpenter CC; Parks RE; Abushanab E; Abernethy DR
J Acquir Immune Defic Syndr (1988); 1991; 4(2):178-82. PubMed ID: 1987354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
